BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 17373668)

  • 1. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened.
    van Nagell JR; DePriest PD; Ueland FR; DeSimone CP; Cooper AL; McDonald JM; Pavlik EJ; Kryscio RJ
    Cancer; 2007 May; 109(9):1887-96. PubMed ID: 17373668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.
    van Nagell JR; DePriest PD; Reedy MB; Gallion HH; Ueland FR; Pavlik EJ; Kryscio RJ
    Gynecol Oncol; 2000 Jun; 77(3):350-6. PubMed ID: 10831341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transvaginal sonography as a screening method for the detection of early ovarian cancer.
    DePriest PD; Gallion HH; Pavlik EJ; Kryscio RJ; van Nagell JR
    Gynecol Oncol; 1997 Jun; 65(3):408-14. PubMed ID: 9190966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study.
    Tailor A; Bourne TH; Campbell S; Okokon E; Dew T; Collins WP
    Ultrasound Obstet Gynecol; 2003 Apr; 21(4):378-85. PubMed ID: 12704748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography.
    Van Nagell JR; DePriest PD; Puls LE; Donaldson ES; Gallion HH; Pavlik EJ; Powell DE; Kryscio RJ
    Cancer; 1991 Aug; 68(3):458-62. PubMed ID: 2065264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian cancer screening in asymptomatic postmenopausal women.
    DePriest PD; van Nagell JR; Gallion HH; Shenson D; Hunter JE; Andrews SJ; Powell DE; Pavlik EJ
    Gynecol Oncol; 1993 Nov; 51(2):205-9. PubMed ID: 8276295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian cancer screening.
    van Nagell JR; Gallion HH; Pavlik EJ; DePriest PD
    Cancer; 1995 Nov; 76(10 Suppl):2086-91. PubMed ID: 8635005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound screening for the early detection of ovarian cancer.
    DePriest PD; DeSimone CP
    J Clin Oncol; 2003 May; 21(10 Suppl):194s-199s. PubMed ID: 12743134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women.
    Kurjak A; Prka M; Arenas JM; Sparac V; Merce LT; Corusic A; Ivancic-Kosuta M
    Croat Med J; 2005 Oct; 46(5):757-64. PubMed ID: 16158468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer screening.
    van Nagell JR; DePriest PD; Gallion HH; Pavlik EJ
    Cancer; 1993 Feb; 71(4 Suppl):1523-8. PubMed ID: 8431889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to decrease false-positive cases of ovarian cancer screening by transvaginal sonography.
    Misawa T; Asai M; Higashide K
    J Exp Clin Cancer Res; 1997 Jun; 16(2):217-20. PubMed ID: 9261750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of ovarian findings in asymptomatic postmenopausal women with color Doppler ultrasound.
    Vuento MH; Pirhonen JP; Mäkinen JI; Laippala PJ; Grönroos M; Salmi TA
    Cancer; 1995 Oct; 76(7):1214-8. PubMed ID: 8630900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The search for meaning-Symptoms and transvaginal sonography screening for ovarian cancer: predicting malignancy.
    Pavlik EJ; Saunders BA; Doran S; McHugh KW; Ueland FR; Desimone CP; Depriest PD; Ware RA; Kryscio RJ; van Nagell JR
    Cancer; 2009 Aug; 115(16):3689-98. PubMed ID: 19603478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer.
    Fishman DA; Cohen L; Blank SV; Shulman L; Singh D; Bozorgi K; Tamura R; Timor-Tritsch I; Schwartz PE
    Am J Obstet Gynecol; 2005 Apr; 192(4):1214-21; discussion 1221-2. PubMed ID: 15846205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.
    Rosenthal AN; Fraser LSM; Philpott S; Manchanda R; Burnell M; Badman P; Hadwin R; Rizzuto I; Benjamin E; Singh N; Evans DG; Eccles DM; Ryan A; Liston R; Dawnay A; Ford J; Gunu R; Mackay J; Skates SJ; Menon U; Jacobs IJ;
    J Clin Oncol; 2017 May; 35(13):1411-1420. PubMed ID: 28240969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening.
    Drescher CW; Nelson J; Peacock S; Andersen MR; McIntosh MW; Urban N
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):600-6. PubMed ID: 15066925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Program for early detection of ovarian cancer for women as prophylaxis provided at a municipal hospital].
    Cnota W; Sodowski K; Olesiak-Andryszczak M; Pilch-Kowalczyk M
    Wiad Lek; 2004; 57 Suppl 1():43-7. PubMed ID: 15884203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.
    Stirling D; Evans DG; Pichert G; Shenton A; Kirk EN; Rimmer S; Steel CM; Lawson S; Busby-Earle RM; Walker J; Lalloo FI; Eccles DM; Lucassen AM; Porteous ME
    J Clin Oncol; 2005 Aug; 23(24):5588-96. PubMed ID: 16110018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
    Menon U; Gentry-Maharaj A; Hallett R; Ryan A; Burnell M; Sharma A; Lewis S; Davies S; Philpott S; Lopes A; Godfrey K; Oram D; Herod J; Williamson K; Seif MW; Scott I; Mould T; Woolas R; Murdoch J; Dobbs S; Amso NN; Leeson S; Cruickshank D; McGuire A; Campbell S; Fallowfield L; Singh N; Dawnay A; Skates SJ; Parmar M; Jacobs I
    Lancet Oncol; 2009 Apr; 10(4):327-40. PubMed ID: 19282241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography.
    Sato S; Yokoyama Y; Sakamoto T; Futagami M; Saito Y
    Cancer; 2000 Aug; 89(3):582-8. PubMed ID: 10931457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.